StarD13: a potential star target for tumor therapeutics

Hum Cell. 2020 Jul;33(3):437-443. doi: 10.1007/s13577-020-00358-2. Epub 2020 Apr 9.

Abstract

StarD13 is a tumor suppressor and a GTPase activating protein (GAP) for Rho GTPases. Thus, StarD13 regulates cell survival pathways and induces apoptosis in a p53-dependent and independent manners. In tumors, StarD13 is either downregulated or completely inhibited, depending on the tumor type. As such, and through the dysregulation of Rho GTPases, this affects adhesion dynamics, actin dynamics, and leads to an increase or a decrease in tumor metastasis depending on the tumor grade and type. Being a key regulatory protein, StarD13 is a potential promising candidate for therapeutic approaches. This paper reviews the key characteristics of this protein and its role in tumor malignancies.

Keywords: Cdc42; Rho GTPases; RhoA; RhoGAP; StarD13.

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Down-Regulation
  • GTPase-Activating Proteins / chemistry
  • GTPase-Activating Proteins / genetics*
  • GTPase-Activating Proteins / metabolism
  • Genes, Tumor Suppressor
  • Humans
  • Molecular Targeted Therapy*
  • Neoplasms / drug therapy*
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins / chemistry
  • Tumor Suppressor Proteins / genetics*
  • Tumor Suppressor Proteins / metabolism
  • rho GTP-Binding Proteins

Substances

  • GTPase-Activating Proteins
  • STARD13 protein, human
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
  • rho GTP-Binding Proteins